Implications of the HDAC6-ERK1 feed-forward loop in immunotherapy

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• The oncogene HDAC6 regulates cell processes crucial for tumorigenesis and metastasis.
• The ERK cascade is a vital pathway in oncogenesis, with its components frequently altered or essential in cancer.
• Interactions between HDAC6 and ERK in tumor proliferation involve mutual regulation via posttranslational modifications.

Purpose of the Study:

• To review the interaction between HDAC6 and the ERK cascade in cancer.
• To explore the connection between HDAC6, ERK, and the immune system.
• To discuss the potential of targeting HDAC6 and ERK in cancer immunotherapy.

Main Methods:

• Literature review of published studies on HDAC6, ERK, cancer, and immunology.
• Analysis of preclinical evidence supporting cotargeting strategies.
• Examination of HDAC6 and ERK roles in T cell maturation and immune cell function.

Main Results:

• HDAC6 and ERK pathways are interconnected and regulate each other through posttranslational modifications.
• Cotargeting HDAC6 and ERK shows promise for enhanced efficacy in cancer treatment compared to single-agent therapies.
• Both HDAC6 and ERK influence T cell maturation, suggesting a role in immune regulation.

Conclusions:

• The interplay between HDAC6 and ERK is significant in cancer pathology and proliferation.
• Targeting both HDAC6 and ERK pathways presents a viable strategy for improving cancer therapy.
• The involvement of HDAC6 and ERK in immune cell function opens avenues for novel immunotherapy approaches.